Reuters logo
BRIEF-Zynerba Pharmaceuticals reports Q3 loss per share of $0.63
November 14, 2017 / 12:49 PM / in a month

BRIEF-Zynerba Pharmaceuticals reports Q3 loss per share of $0.63

Nov 14 (Reuters) - Zynerba Pharmaceuticals Inc

* Zynerba Pharmaceuticals reports third quarter 2017 financial results and operational highlights

* Q3 loss per share $0.63

* Q3 earnings per share view $-0.59 -- Thomson Reuters I/B/E/S

* Zynerba Pharmaceuticals - ‍ believes cash and cash equivalent position as of September 30, 2017 is sufficient to develop five phase 3-ready programs

* Zynerba Pharmaceuticals Inc - believes that cash and cash equivalent position of as of September 30, 2017 is sufficient to fund operations into 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below